REG - One Health Group PLC - Trading Statement

One HealthAnnouncement

24/04/2025 07:02

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250424:nRSX9374Fa&default-theme=true

RNS Number : 9374F  One Health Group PLC  24 April 2025

 

24 April 2025

 

One Health Group plc

("One Health", the "Company" or the "Group")

Full Year Trading Update

 

One Health Group plc (AIM: OHGR), an independent provider of NHS-funded
medical procedures, for patients referred through 'Patient Choice' for
treatment in Orthopaedics, Spine, General Surgery, Gynaecology and Urology, is
pleased to provide the following trading update for the year ended 31 March
2025 ("FY25").

Financial Highlights

·     Financial results for the year are expected to be in line with
market expectations with full year revenue of approximately £28 million
(FY24: £23.0 million) an organic increase of more than 22%.

·      FY25 underlying EBITDA expected to be in line with current market
expectations.

·   The Company listed on AIM on 20 March raising £7.8 million, with net
proceeds to the Company of approximately £5.6 million and £2.2 million gross
proceeds to selling shareholders.

·     Following the fundraise, year-end cash was £11.4 million
(including cash in the Employee Benefit Trust of £1.2 million) (FY24: £4.7
million) providing substantial resources for investment in growth, including
funding of our first surgical hub.

Operational Highlights

·    The Group has maintained the strong momentum established in H1 25
delivering a 28% increase in new NHS patient referrals to 17,020 for the year
(FY24:13,266), a new record.

·      Total patient consultations of 42,238 delivered, an increase of
25% (FY24: 33,695).

·     A total of 7,043 surgical procedures delivered for NHS patients
(FY24: 6,169) a 14% increase, delivered through 9 independent hospitals.

·    A total of 80 NHS Consultants provided their services to the Group
over the year, an increase of 27% (FY24: 63).

·      Introduced Urology to the range of procedures provided to support
a wider population of NHS patients.

·     Established 5-year contracts with the Group's largest NHS
commissioners representing approximately 70% of revenue, moving away from the
historic annual renewal process and derisking future revenue streams.

·      Contracts exchanged to purchase land in the North of England with
full planning submitted in March 2025 for the construction of the first
Surgical Hub which is expected to deliver significant additional operating
capacity in 2026.

·     Support provided to six NHS trusts over the year with internal
waiting list reductions with NHS waiting list patient transfers representing
10% of full year revenue.

·    New agreement between the NHS and independent sector announced on 6
January 2025 to help tackle waiting lists and actively promote 'greater
patient choice' with the NHS increasingly looking to independent providers for
additional support.

 

The Group intends to announce its full year results around the end of June
2025.

 

Adam Binns, Chief Executive Officer, said:

 

"We are very pleased with the performance of the business over the last twelve
months and delighted to have raised £7.8 million on our admission to AIM to
support the development of our first surgical hub and welcome new investors
onto the share register. Organic growth in advance of the hub being completed
remains strong, with One Health Group continuing to perform well over the
second half of the financial year, well ahead of last year, and setting
another new record for new NHS patients choosing One Health through Patient
Choice. In addition, we have continued to support local NHS Trusts with their
internal patient waiting lists, further reducing the pressure on the NHS and
generating a new revenue stream for the Company. The record number of new
surgeons applying to provide their services to the Group is testament to the
benefits that the Group provides to the wider community of NHS patients.

 

"We look forward to the future with confidence, as our business model for
providing surgical care, free at the point of delivery, becomes more widely
adopted to reduce the pressure of waiting lists, expanding our support of the
NHS through Patient Choice."

 

 

The Directors of One Health Group plc accept responsibility for the contents
of this announcement.

 

For more information, please contact:

 

 One Health Group plc                           via Square1 Consulting

 Derek Bickerstaff, Chairman

 Adam Binns, CEO

 Panmure Liberum, Nominated Adviser and Broker  Tel: +44 (0) 20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Square1 Consulting                             Tel: +44 207 929 5599

 David Bick                                     +44 7831 381201

Further information on the Company can be found on its website at
www.onehealth.co.uk (http://www.onehealth.co.uk) .

About One Health Group plc

One Health engages 80 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and, in the year, to
March 2025 provided much needed care to 17,020 new patients, through over
42,000 consultations and over 7,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. Currently, the Company's activities are focused in Yorkshire,
Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is
derived from over 60 NHS commissioning bodies in addition to contracts with
local NHS Hospital Trusts to transfer their internal waiting list patients to
One Health for quicker treatment.

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology, with urology introduced
at the end of FY25.

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

*(https://www.onehealth.co.uk/investors
(https://www.onehealth.co.uk/investors) )

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTMZGZDNFMGKZM